Radeberg, Germany Clinical Trials

A listing of Radeberg, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 73 clinical trials
Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML

To compare the event-free survival at 2 years of CPX-351 vs. conventional care regimens before allogeneic blood cell transplantation as first line treatment in patients with higher risk MDS and oligoblastic AML.

blast cells
bone marrow procedure
serum bilirubin level
Universit tsklinikum Carl Gustav Carus Dresden
 (7.4 away) Contact site
  • 26 Jan, 2021
  • +25 other locations
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

The purpose of this study is to compare the ability of eltrombopag in combination with a short course of high-dose dexamethasone to induce sustained response off treatment in patients with newly-diagnosed ITP versus 1-3 cycles of dexamethasone monotherapy. The unmet clinical need and the potential for eltrombopag when added to …

platelet count
Novartis Investigative Site
 (7.4 away) Contact site
  • 02 Jul, 2021
  • +19 other locations
A Study to Evaluate the Efficacy Safety Tolerability and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation

A randomized, placebo-controlled, investigator- and participant-blinded study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of HSY244 in participants with AF.

body mass index
anticoagulation therapy
Novartis Investigative Site
 (7.4 away) Contact site
  • 30 Jul, 2021
  • +6 other locations
Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer)

This study evaluates whether the adoption of the RADAR dosing strategy could further reduce treatment related toxicities improving the safety profile of niraparib.

direct bilirubin
neutrophil count
ovarian cancer
cancer of the ovary
University Hospital Dresden
 (8.8 away) Contact site
  • 20 Jun, 2021
  • +11 other locations
Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

MDS/AML with MRD and impending relapse after allogeneic stem cell transplantation and/or conventional chemotherapy

Medizinischen Klinik und Poliklinik I / H matologie, Universit tsklinikum Carl Gustav Carus an der Technischen Universit t Dresden
 (8.8 away) Contact site
  • 05 May, 2021
  • +13 other locations
Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Patients with moderate to severe COVID-19 present a very high risk of thromboembolic disease.This multicenter, prospective, randomized, event-driven study evaluates rivaroxaban compared with standard of care including low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) at prophylactic doses if applicable in the prevention of the composite of venous thromboembolism (deep vein …

Medical Clinic I. Universit tsklinikum Carl Gustav Carus, Dresden
 (7.4 away) Contact site
  • 23 Jun, 2021
  • +33 other locations
Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Compensated Liver Cirrhosis

Open-label, single arm, multicenter phase II trial assessing the tolerability of a reduced starting dose of 40 mg cabozantinib for 4 weeks and subsequent dose escalation to 60 mg cabozantinib until disease progression or intolerable toxicities.

BAG / Onkologische Gemeinschaftspraxis
 (7.4 away) Contact site
  • 25 Feb, 2021
  • +6 other locations
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail

This study will be a multicenter, international, randomized, vehicle-controlled, parallel-group, double-blinded study. Subjects who are eligible to participate with a confirmed diagnosis of Distal Subungual onychomycosis (DSO) of the toenail will be randomized and participate in one of the following treatment groups: BB2603-1: 0.01% terbinafine/0.03% polyhexanide formulation, or BB2603-3: 0.03% …

Uniklink Carl Gustav Carus, Klinik und Polyklinik f r Dermatologie
 (8.8 away) Contact site
  • 26 Apr, 2021
  • +24 other locations
Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan ) in Recurrent Glioblastoma

In this multicenter, randomized, non-blinded trial the efficacy and safety of stereotactical photodynamic therapy with 5-aminolevulinic acid will be investigated in 106 patients with recurrent glioblastoma.

Medizinische Fakult t Carl Gustav Carus, Klinik und Poliklinik f r Neurochirurgie
 (7.4 away) Contact site
  • 27 Apr, 2021
  • +4 other locations
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)

AIO-YMO/TRK-0416 (DURATION) is a open-label, treatment stratified and randomized phase II study of Durvalumab, frail or elderly patients with metastatic non-squamous NSCLC with no targetable molecular alterations (EGFRwt; ALKtransl-) and not amenable to cisplatinum-based standard-combination chemotherapy but eligible for at-least mono-chemotherapy with gemcitabine or vinorelbine.

kidney function test
Universit tsklinikum Carl-Gustav-Carus
 (7.4 away) Contact site
  • 29 Jan, 2021
  • +40 other locations